← Back to Search

UV Photo for Melanoma

N/A
Waitlist Available
Led By Neil Box, PhD
Research Sponsored by University of Colorado, Denver
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up start of study to end of study, up to 3 years
Awards & highlights

Study Summary

This trial looks at the role of genetics and sun exposure in causing melanoma.

Eligible Conditions
  • Nevi and Melanoma
  • Melanoma

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~start of study to end of study, up to 3 years
This trial's timeline: 3 weeks for screening, Varies for treatment, and start of study to end of study, up to 3 years for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Genetics Correlations
Sun Exposure Behaviors
UV Exposure Assessment
+8 more
Secondary outcome measures
Behavioral Intervention and Immediate Follow Up
Benign Nevi, DNA
Benign Nevi, Exposure
+7 more

Trial Design

3Treatment groups
Experimental Treatment
Group I: Visual Analysis - UV PhotoExperimental Treatment1 Intervention
Assess the relationships between UV camera score, silicone mold of a skin patch, phenotypic evaluation and sun-exposure behaviors. Technically, this arm is a sub-study that does not involve an intervention. Patients are not receiving an intervention; they are simply providing data to the study team.
Group II: UV CounselingExperimental Treatment1 Intervention
Evaluate the effectiveness of dosimetry feedback on sun exposure behaviors, attitudes, and awareness in patients diagnosed with melanoma.
Group III: Biological SampleExperimental Treatment1 Intervention
Determine the relationship between measures of sun exposure and genomic characteristics of tumors in melanoma patients. Technically, this arm is a sub-study that does not involve an intervention. Patients are not receiving an intervention; they are simply providing data to the study team.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
UV Counseling
2017
N/A
~80

Find a Location

Who is running the clinical trial?

University of Colorado, DenverLead Sponsor
1,726 Previous Clinical Trials
2,141,605 Total Patients Enrolled
10 Trials studying Melanoma
275 Patients Enrolled for Melanoma
Neil Box, PhDPrincipal InvestigatorUniversity of Colorado, Denver

Media Library

UV Photo Clinical Trial Eligibility Overview. Trial Name: NCT03783325 — N/A
Melanoma Research Study Groups: UV Counseling, Visual Analysis - UV Photo, Biological Sample
Melanoma Clinical Trial 2023: UV Photo Highlights & Side Effects. Trial Name: NCT03783325 — N/A
UV Photo 2023 Treatment Timeline for Medical Study. Trial Name: NCT03783325 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

How extensive is the cohort of participants in this medical research?

"Affirmative, the trial is actively seeking participants according to clinicaltrials.gov records. It first appeared on February 17th 2017 and was last edited April 4th 2022 with a need for 400 patients from 1 location."

Answered by AI

Are there any vacancies still available for this medical research?

"Affirmative. Clinicaltrials.gov's records indicate that this clinical trial, first published on February 17th 2017, is presently recruiting patients. 400 participants are needed at a single site of administration."

Answered by AI

What is the overarching goal of this research project?

"The main goal of this trial, to be assessed from the moment participants join, is to determine UV exposure levels. Secondary aims include examining the correlation between primary melanomas and somatic mutations, evaluating personalized feedback plans using dosimetry readings over time, and determining if there's a connection between benign nevi and genomic DNA."

Answered by AI
~9 spots leftby Mar 2025